Special Biotech Insert, La Presse. October 7, 2004. In a randomized double blind placebo-controlled clinical study conducted at Maisonneuve-Rosemont Hospital in 2004, we observed a considerable improvment in digestive health in patients that received Bio-K+^®, as compared to the placebo group. Consumption of Bio-K+^® also led to a 20% reduction in the length of hospital stays for patients in the Bio-K+^® group when compared with the patients in the placebo group. Noting the results, Dr Serge Carrière observed that “patients treated with Bio-K+^® products experienced 56% less secondary effects than other patients and required 20% less hospitalization time.” This important improvement is attributed to the unique and patented formula of Bio-K+ CL1285^® of L. acidophilus CL1285^® and L. casei LBC80R^® .